6.5 C
New York
Tuesday, January 25, 2022

Novavax reports 90.4% efficacy against COVID-19 infection

Must Read

What options the US has to control and punish Russia if it attacks Ukraine

How the US can control and win over Russia - some options If Russia...

Why some obese people remain healthy while others develop type 2 diabetes and heart disease, study explains

A new study has found why some people are less prone to heart disease and type 2...

Does Meat-Eating Make Us Smarter?

The study adds subtlety to the "meat made us human" notion, and they may be of interest...
Kuldeep Singh
Kuldeep is a Journalist and Writer at Revyuh.com. He writes about topics such as Apps, how to, tips and tricks, social network and covers the latest story from the ground. He stands in front of and behind the camera, creates creative product images and much more. Always ready to review new products. Email: kuldeep (at) revyuh (dot) com

The Novavax vaccine is 90.4 per cent effective at preventing COVID-19 infection, according to the company’s phase 3 trial.

Novavax gave at least one dose of the vaccine to nearly 20,000 people, with about 10,000 receiving a placebo (sugar pill). Over three months, 14 vaccinated participants tested positive to COVID-19 and 77 placebo participants tested positive.

Ten moderate and four severe cases occurred, all in the placebo group. Of the COVID-19 cases that were sequenced, four in five were a variant of interest or variant of concern.

Soon updating more…

Source: 10.1056/NEJMoa2116185

You were reading: Novavax reports 90.4% efficacy against COVID-19 infection

- Advertisement -
- Advertisement -

Latest News

- Advertisement -

More Articles Like This

- Advertisement -